Hair Therapy & Transplantation
Open Access

Pathophysiology of Naxos Disease: A Rare Genetic Disorder with Serious Implications

Rivka Maleki^{* *}Correspondence: Rivka Maleki, Department of Dermatology, University of Oulu, Oulu, Finland, Email:

Author info »

Description

Naxos disease is a rare but serious genetic disorder that primarily affects the heart, skin, and hair. First described in 1986, it is characterized by a combination of Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) and woolly hair with palmoplantar keratoderma (thickening of the skin on the palms of the hands and soles of the feet). This disorder has a profound impact on individuals affected by it, and its clinical manifestations can be devastating if not properly managed.

Genetic basis of naxos disease

Naxos disease is inherited in an autosomal dominant pattern, meaning that a single copy of the altered gene is enough to cause the disorder. The condition is caused by mutations in the Desmoplakin (DSP) gene, which plays a crucial role in maintaining the structural integrity of the heart muscle and skin cells. Desmoplakin is a protein that helps form desmosomes, structures that connect individual heart muscle cells (cardiomyocytes) and skin cells (keratinocytes) together.

In Naxos disease, mutations in DSP disrupt the normal function of desmosomes, leading to defects in both the heart and skin. The heart muscle, particularly in the right ventricle, becomes prone to electrical disturbances and structural damage, leading to arrhythmias and potential heart failure. On the skin, the absence of functional desmoplakin results in thickening and abnormal growth patterns of the skin on the palms and soles. The scalp hair also becomes coarse and woolly, which is a hallmark feature of the disease.

Symptoms and clinical features

The most prominent symptoms of Naxos disease can be grouped into three major categories: cardiac, dermatological, and hair-related.

Cardiac Symptoms: The heart involvement in Naxos disease is primarily seen in the form of ARVC. ARVC is a condition where the right ventricle of the heart becomes weakened and is prone to abnormal electrical activity. This can lead to arrhythmias, which are irregular heartbeats that can range from benign to life-threatening.

Dermatological Symptoms: The most noticeable dermatological feature of Naxos disease is palmoplantar keratoderma, which causes thickened, rough skin on the palms of the hands and the soles of the feet. This thickening can lead to painful fissures and calluses.

Diagnosis of naxos disease

Diagnosing Naxos disease can be challenging due to its rarity and the overlap of symptoms with other more common conditions. However, a thorough clinical evaluation combined with genetic testing can help confirm the diagnosis. Key diagnostic methods include:

Electrocardiogram (ECG): To assess the electrical activity of the heart, identify arrhythmias, and look for signs of right ventricular involvement.

Echocardiography: Evaluate the structure and function of the heart, especially the right ventricle.

Genetic testing: Identifying mutations in the gene can confirm the diagnosis.

Management and treatment

Currently, there is no cure for Naxos disease, and treatment is largely focused on managing symptoms and preventing complications, particularly the risk of sudden cardiac death. The management approach typically includes:

Antiarrhythmic medications may be used to control arrhythmias.

Implantable Cardioverter-Defibrillator (ICD): May be recommended to prevent sudden cardiac death due to life-threatening arrhythmias.

Heart transplantation: May be considered in cases where heart failure progresses despite other treatments.

Dermatological Care: Topical treatments such as emollients and keratolytic agents can help manage the skin thickening associated with palmoplantar keratoderma.

Hair Care: There is no specific treatment for the hair abnormalities in Naxos disease, but gentle hair care products and avoiding trauma to the hair can reduce hair breakage and thinning.

Prognosis and future directions

The prognosis of Naxos disease largely depends on the severity of cardiac involvement and the timely management of arrhythmias. Early diagnosis and intervention, particularly with regard to preventing arrhythmias, are key to improving long-term outcomes. With appropriate treatment, many individuals with Naxos disease can lead relatively normal lives, although they may need to undergo lifelong monitoring for heart issues.

In recent years, there has been growing interest in exploring potential therapies for Naxos disease, including gene therapy and drugs that target the underlying molecular defects. However, due to the rarity of the condition, large-scale clinical trials are difficult to conduct, and much remains to be learned about the best approaches to managing the disease.

Conclusion

Naxos disease, though rare, is a serious genetic disorder that can significantly affect an individual's quality of life. Early diagnosis, genetic counseling, and a multidisciplinary approach to treatment are essential for managing the cardiac, dermatological, and hair-related symptoms of the disease. As research into genetic disorders progresses, there is hope that more effective treatments will emerge, improving the outlook for individuals living with Naxos disease.